Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Roche drug in Covid trial

Posted 12 May 2020

Queensland researchers are gearing up to trial Roche's immunoregulatory drug Actemra in critically ill patients with COVID-19, based on the hope that the drug can interrupt a process that contributes to severe respiratory failure.

While there are a number of randomised controlled trials around the world evaluating the drug, lead researcher Bridget Barber from the QIMR Berghofer Medical Research Institute says the Brisbane trial is important.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended